Please ensure Javascript is enabled for purposes of website accessibility

Emergent BioSolutions(EBS)

New York Stock Exchange

EBS
Emergent BioSolutions Stock Quote
$41.89 -$0.83 -1.9%
Price as of December 3, 2021, 4:00 p.m. ET View Interactive EBS Charts

Emergent BioSolutions makes the only FDA-approved anthrax vaccine.

Interactive Chart


Compare EBS Stock to Peers


Symbol Last Price Market Cap % Δ 1 Yr % Δ 5 Yr
EBS
Emergent BioSolutions
$41.89 $2B -49.4% 52.3%
NVTA
$14.99 $3B -70.5% 112.6%
EDIT
$27.72 $2B -19.6% 75.9%
IONS
$26.39 $4B -48.5% -42.6%
CRLBF
$8.09 $5B -24.8%

News & Analysis: Emergent BioSolutions

The Fool has written over 100 articles on Emergent BioSolutions.

All

Market Moves

Earnings